Science News
from research organizations

Metabolomics as a basis for gender-specific drugs

Date:
August 11, 2011
Source:
Public Library of Science
Summary:
Analyses of the metabolic profile of blood serum have revealed significant differences in metabolites between men and women. Scientists have concluded that there is a need for gender-specific therapies.
Share:
       
Total shares:  
FULL STORY

Analyses of the metabolic profile of blood serum have revealed significant differences in metabolites between men and women. In a study to be published on August 11 in the open-access journal PLoS Genetics, scientists at the Helmholtz Zentrum München have concluded that there is a need for gender-specific therapies.

Gender-specific therapies may be required for some diseases as there are significant differences between male and female metabolism. Such differences were shown to exist for 101 of the 131 metabolites -- above all in lipid and amino acid species -- in the sera of more than 3,000 volunteers who took part in the population-based KORA study. Professor Thomas Illig and Dr. Kirstin Mittelstrass see this as proof that "in terms of molecular profiles, men and women have to be assigned to two completely different categories. That means that we also need gender-specific approaches to the treatment of diseases."

The researchers combined genetic data with metabolic profiles, which indicate the metabolic paths that are active given the specific conditions. The combination of genetics and metabolomics provides insight into the causes and progression of specific diseases. This could allow new therapeutic approaches and drugs to be developed, and enable markers to be found for the early recognition of diseases such as diabetes.

In the next phase, the scientists will increase the number of metabolites and evaluate further studies from a gender-specific point of view. "Through the combination of gender-specific evaluation, genetic association studies and metabolomics we will gain a detailed understanding of how major widespread diseases such as diabetes mellitus develop," Professor Illig says.


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. Kirstin Mittelstrass, Janina S. Ried, Zhonghao Yu, Jan Krumsiek, Christian Gieger, Cornelia Prehn, Werner Roemisch-Margl, Alexey Polonikov, Annette Peters, Fabian J. Theis, Thomas Meitinger, Florian Kronenberg, Stephan Weidinger, Heinz Erich Wichmann, Karsten Suhre, Rui Wang-Sattler, Jerzy Adamski, Thomas Illig. Discovery of Sexual Dimorphisms in Metabolic and Genetic Biomarkers. PLoS Genetics, 2011; 7 (8): e1002215 DOI: 10.1371/journal.pgen.1002215

Cite This Page:

Public Library of Science. "Metabolomics as a basis for gender-specific drugs." ScienceDaily. ScienceDaily, 11 August 2011. <www.sciencedaily.com/releases/2011/08/110811181710.htm>.
Public Library of Science. (2011, August 11). Metabolomics as a basis for gender-specific drugs. ScienceDaily. Retrieved May 23, 2015 from www.sciencedaily.com/releases/2011/08/110811181710.htm
Public Library of Science. "Metabolomics as a basis for gender-specific drugs." ScienceDaily. www.sciencedaily.com/releases/2011/08/110811181710.htm (accessed May 23, 2015).

Share This Page:


Health & Medicine News
May 23, 2015

Latest Headlines
updated 12:56 pm ET